Navigation Links
Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing
Date:11/9/2009

ks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from those referred to or implied in the forward-looking statements. Such risks include, but are not limited to, the risk that Anesiva otherwise fails to comply with the continued listing requirements of The NASDAQ Global Market or any other NASDAQ market; the risk that the parties to the Merger will be unable to satisfy the conditions to closing the Merger or otherwise complete the Merger; the risk of whether certain market segments grow as anticipated; clinical trial results; the competitive environment in the biotechnology industry; and whether the Anesiva can successfully develop new products and the degree to which these gain market acceptance as well as other risks detailed from time to time in Anesiva's filings with the SEC, including Anesiva's most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2008, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K as filed with the SEC. Anesiva expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Anesiva's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Anesiva, Inc.


'/>"/>
SOURCE Anesiva, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
2. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
3. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
4. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
5. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
6. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
7. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
10. Anesiva Defines Regulatory Pathway for Adlea with FDA
11. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... of the "US ACO IT Spending Outlook 2018" ... expected that number of lives covered by ACO would ... In this report, the ACO IT spending has been ... spending on software and spending on services. Our research ...
(Date:5/1/2015)... Calif. , May 1, 2015  Thoratec Corporation (NASDAQ: ... therapies to save, support and restore failing hearts, announced today ... newly created role of President, International. This new ... Thoratec commercial operations outside of North America ... , and Latin America , and ...
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
Breaking Medicine Technology:United States ACO IT Spending Outlook 2014-2018 2Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... SAN DIEGO, Dec. 12, 2011  Daiichi Sankyo Company, Limited ... pooled analysis showing that edoxaban, a direct oral once-daily ... venous thromboembolism (VTE) following total knee or hip arthroplasty, ... lower incidence of a composite of deep vein thrombosis ...
... Partnership (SRP) Inc. today announced the availability of ... Third Party Administrators (TPAs), brokers, and other users to ... software tools and the need for expensive outsourcing, SRP,s ... affordable licensing rates with no initial subscription fees. ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans 2
(Date:5/3/2015)... Metamora, Michigan (PRWEB) May 03, 2015 ... mark on their Facebook page. , Their ... on the many services the Practice has, it’s multiple ... events. , Women’s Excellence has a very strong social ... Pinterest, Instagram and You Tube. , Women’s Excellence ...
(Date:5/3/2015)... " Bubbly Walrus ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... games to play on smartphones are the ones that get ... with a video game that just absorbs attention, why not ...
(Date:5/3/2015)... May 03, 2015 Looking for ... will directly impact your career? The Master of ... dynamic leaders in multinational companies and for professionals ... a changing global landscape, differences in culture, religion, ... The EMIB program develops the global competence and ...
(Date:5/3/2015)... 2015 It is not too late to register ... in Memory of Lissa Anne Been in Arnold, Missouri on ... family-friendly event to honor her loving memory. It has benefited the ... Just having turned 37, Lissa suffered a brain aneurysm . ... 24, 2012. This event is designed to serve as a remembrance ...
(Date:5/2/2015)... Las Vegas, NV (PRWEB) May 02, 2015 ... vs. Pacquiao tickets for the long awaited event today, ... Las Vegas. Diehard boxing fans will be able to ... circuit events. , The fight that boxing fans have wanted ... a few months ago. Floyd “Money” Mayweather will step inside ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... WHITE PLAINS, N.Y., Feb. 25 When Jacqueline,Savage ... products,splashed in luscious color, got the devastating news that ... it brought,things into perspective for her. It also created ... Presley, president and CEO,Carolina Pad & Paper (CPP), with ...
... 100% Nectarine Juices for a Healthier You, ORLANDO, Fla., ... and exercise more in 2008 but still find yourself having ... too late to implement your,New Year,s resolutions and Sun Shower(TM) ... have a healthier 2008., "It,s not too late to ...
... expanded more than 30% in 2007, ... according to Millennium Research Group, WALTHAM, Mass., ... small-diameter (less than or equal to 3.0 mm),dental implants are ... growing at a faster rate than those of regular-diameter,(> 3.0 ...
... An experimental anti-HIV gel is safe for women ... at the University of Alabama at Birmingham (UAB) and ... showed the gel, called tenofovir, was favorably self-applied and ... and AIDS prevention efforts focused on next-generation microbicides to ...
... a survey of over 3.6 million patient records held by ... undiagnosed diabetes. This could help identify tens of thousands of ... is published in the March issue of the British Journal ... of the University of Warwick with colleagues from Nottingham University, ...
... LodgeNet Healthcare to Demonstrate its Interactive Patient Television ... ... Feb. 25 LodgeNet,Healthcare, a unit of LodgeNet Interactive Corporation (Nasdaq: ... that hospitals with,interactive patient television systems enjoyed greater patient satisfaction,ratings and ...
Cached Medicine News:Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 2Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 3Health News:Designer's Young Cousin Inspiration Behind Colorful School and Office Supplies That Raise Awareness for Leukemia 4Health News:Still Time to Make a 'Healthy Diet' New Year's Resolution 2Health News:Small-Diameter Dental Implants Increasingly Popular In the US 2Health News:Anti-HIV gel proven safe, tolerable for women 2Health News:GP's databases could identify tens of thousands with undiagnosed diabetes in UK 2Health News:Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows 2Health News:Interactive Patient Television Drives Patient Satisfaction, LodgeNet Healthcare Study Shows 3
... gel drying system, 100-120 V, includes Model 583 ... Model 583 gel dryer is a vacuum-based gel ... 45 cm with variable temperature control and three ... water-based pump used for pulling vacuum on gel ...
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven....
... is the most versatile power supply in ... 1000 volts or 1250 milliamps or 325 ... other 1000 volt power supply is capable ... protein gels or small focusing gels and ...
... DNA sequencing, Thermo Series 90 high voltage ... applications. These power supplies can operate ... power operating modes, with automatic crossover. To ... the Series 90 power supplies, four sets ...
Medicine Products: